Kara M. Magane, MS
Senior Director of Research Operations
Boston University School of Public Health
Health Law, Policy & Management




Kara Magane, MS, is Senior Director of Research Operations at the Boston University School of Public Health, where she manages a broad research portfolio spanning multiple departments on the BU Medical Campus. She supports the design, coordination, and implementation of large, complex, and multi-site studies, with a focus on building and sustaining research infrastructure and facilitating collaboration among investigators, teams, and external partners. Her work emphasizes operational efficiency, regulatory compliance, and research integrity.

She joined BU in 2019 following research roles at Boston Children’s Hospital and the University of Pennsylvania, where she contributed to studies focused on substance use and colorectal cancer screening. She holds a Master of Science in Health Promotion and a Bachelor of Arts in Sociology, magna cum laude, from the University of Delaware.

Her research contributions have been published in journals including JAMA Internal Medicine, Addiction Science & Clinical Practice, and Pediatrics, with a focus on substance use, HIV, and chronic disease.


CTN New England Consortium Node (CTN-0098)
03/01/2025 - 02/28/2026 (Subcontract PI)
Yale University NIH NIDA
2UG1DA015831-24

NorthStar Node of the Clinical Trials Network
06/01/2020 - 02/28/2026 (Subcontract PI)
Hennepin Healthcare Research Institute NIH NIDA
2UG1DA040316-11

The National Drug Abuse Treatment Clinical Trials Network: New England Consortium Node
06/01/2020 - 02/28/2025 (Subcontract PI)
Yale University NIH NIDA
5UG1DA015831-23



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Sheinin J, Brothers TD, Stein MD, Winter MR, Palfai TP, Magane KM, Bellamy S, Asbridge M, Kim TW. Cocaine Use, Unhealthy Alcohol Use, and Pain Interference Among People with HIV. AIDS Behav. 2026 Jan 05. PMID: 41491897; DOI: 10.1007/s10461-025-05012-2;
     
  2. Siebers R, Magane KM, Slayton H, Karzhevsky S, Palfai TP, Abrantes AM, Quintiliani LM, Stein MD. Lessons Learned Identifying and Controlling Fraudulent Participation in Online Randomized Trials. J Med Internet Res. 2025 Oct 29; 27:e77512. PMID: 41160082; PMCID: PMC12612639; DOI: 10.2196/77512;
     
  3. Weinstein ZM, Magane KM, Lodi S, Doeleman D, Ventura AS, Bazzi AR, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R. Associations between COVID impact domains and time to buprenorphine treatment disengagement. Am J Drug Alcohol Abuse. 2025; 51(6):776-785.View Related Profiles. PMID: 40906491; DOI: 10.1080/00952990.2025.2544660;
     
  4. Theisen J, Weinstein ZM, Davoust M, Ventura AS, Magane KM, Cheng A, Blakemore S, Blodgett J, Fielman S, Saitz R, Bazzi AR. Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment. Subst Use Addctn J. 2026 Jan; 47(1):144-152.View Related Profiles. PMID: 40876939; PMCID: PMC12498346; DOI: 10.1177/29767342251360850;
     
  5. Taghian NR, Palfai TP, Winter MR, Kim TW, Magane KM, Saitz R, Stein MD. Pain and alcohol consumption among people living with HIV: examining the moderating roles of depression and social support. Alcohol. 2025 Nov; 128:13-20.View Related Profiles. PMID: 40712846; PMCID: PMC12433698; DOI: 10.1016/j.alcohol.2025.07.002;
     
  6. Magane KM, Dukes KA, Fielman S, Palfai TP, Regan D, Cheng DM, Lee H, Kraemer KL, Bullard MJ, Chen CA, Samet JH. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):635-645.View Related Profiles. PMID: 40257810; PMCID: PMC12013356; DOI: 10.1001/jamainternmed.2025.0522;
     
  7. Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study. Addict Sci Clin Pract. 2025 Mar 04; 20(1):21.View Related Profiles. PMID: 40033433; PMCID: PMC11877703; DOI: 10.1186/s13722-025-00536-3;
     
  8. Magane KM, Saitz R, Fielman S, LaRochelle MR, Shanahan CW, Pace CA, LaValley M, Penington K, Karzhevsky S, Hurstak E. Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial. Addict Sci Clin Pract. 2025 Feb 05; 20(1):9.View Related Profiles. PMID: 39910606; PMCID: PMC11800519; DOI: 10.1186/s13722-024-00526-x;
     
  9. Bart G, Barth KS, Baukol P, Enns E, Ghitza UE, Harris J, Jelstrom E, Liebschutz JM, Magane KM, Voronca D, Weinstein ZM, Korthuis PT. Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder. Addict Sci Clin Pract. 2024 Dec 02; 19(1):91.View Related Profiles. PMID: 39623502; PMCID: PMC11610182; DOI: 10.1186/s13722-024-00510-5;
     
  10. Y Bernstein E, Magane KM, Dukes KA, Palfai TP, Lee JH, Saitz R, Samet JH. Correlates of post-hospitalization naltrexone adherence for alcohol use disorder. Drug Alcohol Depend. 2024 Dec 01; 265:112470.View Related Profiles. PMID: 39461121; PMCID: PMC11884669; DOI: 10.1016/j.drugalcdep.2024.112470;
     
Showing 10 of 36 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 36 publications over 9 distinct years, with a maximum of 11 publications in 2024

YearPublications
20183
20193
20202
20212
20223
20234
202411
20257
20261

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Alcoholism
Opioid-Related Disorders
HIV Infections
Substance-Related Disorders
Contact for Mentoring:

715 Albany Street, Talbot 356W
Boston MA 02118
Google Map


Magane's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department